Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalBone Marrow TransplantationCombined Modality TherapyGraft SurvivalHematopoietic Stem CellsCyclophosphamideBusulfanStem CellsMyeloablative AgonistsMultiple MyelomaTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeWhole-Body IrradiationThiotepaHistocompatibility TestingHematopoiesisTransplantation, IsogeneicDisease-Free SurvivalInfectionImmunosuppressive AgentsVidarabineRetrospective StudiesAmyloidosisSalvage TherapyLeukemiaIfosfamideSurvival RateBlood CellsVincristineSurvival AnalysisCarmustineGraft vs Leukemia EffectTime FactorsCytarabineHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticLymphocyte DepletionBlood Cell CountLymphomaCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsBone MarrowFatal OutcomeLivedo ReticularisHistiocytosis, Non-Langerhans-CellFeasibility StudiesFollow-Up StudiesOpportunistic InfectionsHematologic DiseasesImmunophenotypingDoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineHLA AntigensBlood DonorsImmunosuppressionCell TransplantationRecombinant ProteinsProspective StudiesMesenchymal Stem Cell TransplantationLymphoma, T-CellBone Marrow PurgingPilot ProjectsPrednisoneAntigens, CDBone Marrow CellsCarboplatinBone Marrow DiseasesLeukocyte CountT-LymphocytesFlow Cytometry